Novartis brief argues lower court was right to dismiss Gleevec pay-for-delay case
MLex Summary: Novartis filed a brief in response to plaintiffs’ appeal of the order that dismissed antitrust claims Norvatis over the drug Gleevec. “The end payor plaintiffs’ amended complaint does not...To view the full article, register now.
Already a subscriber? Click here to view full article